Representing Georgia patients diagnosed with lymphoma or cancer after taking Dupixent (dupilumab)
If you or a loved one in Georgia used Dupixent® and were later diagnosed with T-cell lymphoma, cutaneous T-cell lymphoma (CTCL), Mycosis Fungoides, or Sézary syndrome, you may have a right to file a Dupixent lawsuit.
At Fob James Law Firm, our experienced mass tort attorneys represent clients across Atlanta, Columbus, Macon, Savannah, and throughout Georgia.
We hold major pharmaceutical companies like Regeneron Pharmaceuticals and Sanofi Genzyme accountable when their products cause harm.
Our team fights for full compensation for your medical expenses, lost income, pain and suffering, and more.
Why Choose Fob James Law Firm for Your Dupixent Lawsuit
When Dupixent (dupilumab) causes severe reactions, you need a legal team that understands the medical science behind your injuries. At Fob James Law Firm, our attorneys partner with board-certified dermatologists, immunologists, and allergy specialists to review your medical records and document the full extent of your Dupixent-related harm.
Why clients trust our Dupixent legal team:
- Comprehensive medical record evaluations by top specialists
- Deep experience in pharmaceutical and mass tort litigation
- Georgia-based team with real federal and state courtroom experience
- Backed by the power and resources of national drug-injury litigation
- Contingency fee representation — pay nothing unless we win
If you were harmed by Dupixent, we have the medical and legal firepower to fight for the compensation you deserve.
Dupixent Lawsuit: Potential Link to Cutaneous T-Cell Lymphoma (CTCL)
Dupixent (dupilumab) is an injectable biologic drug approved by the U.S. Food & Drug Administration (FDA) to treat conditions such as:
- Moderate-to-severe atopic dermatitis (eczema)
- Certain types of asthma
- Chronic rhinosinusitis with nasal polyps
- Eosinophilic esophagitis (EoE)
Emerging evidence shows a serious concern for some individuals with long-standing, severe eczema. Multiple large database studies and case series report significantly higher rates of cutaneous T-cell lymphoma (CTCL) diagnoses after starting Dupixent, often with rapid clinical worsening or progression shortly after initiation.
While Dupixent does not cause lymphoma in every patient, scientific literature suggests it may unmask or accelerate an underlying lymphoproliferative disorder previously hidden by chronic eczema-like symptoms.
Defendants typically argue that Dupixent only reveals pre-existing lymphoma misdiagnosed as refractory eczema. Yet, with strong dermatopathology, clear biologic mechanisms, time-ordered medical records, and evidence of what the manufacturers knew, plaintiffs can build a compelling case for liability — creating a pathway to substantial verdicts or settlements.
If you were diagnosed with T-cell lymphoma after taking Dupixent, contact our Georgia Dupixent lawsuit attorneys for a free case evaluation.
The Risk of T-Cell Lymphoma Is Real
Several important database studies and case series suggest that Dupixent users have a higher risk of developing (or worsening) CTCL after use.
Large Database Studies
- JAMA Dermatology (April 2024): Analyzed 19,612 atopic dermatitis (AD) patients via TriNetX database. Dupixent users were 4.1x more likely to develop CTCL (OR 4.1, 95% CI 2.1-8.2) vs. non-users. Risk persisted after adjustments; most diagnoses >1 year post-treatment.
- Dermatologic Therapy (August 2024): TriNetX study of 1.18M AD patients. Dupixent linked to 4.6x higher relative risk (RR 4.6, 95% CI 2.5-8.6). Highest in patients >60 and within first year.
- Journal of Allergy and Clinical Immunology (January 2025): FAERS and RNA-Seq analysis. Dupixent showed 30x higher CTCL reporting rate vs. other meds. Suggested mechanism: IL-13 increase accelerates malignant T-cells.
Case Series & Reviews
- JAAD Case Reports (2022): 7 patients with severe AD developed/worsened CTCL after Dupixent. Symptoms progressed rapidly (average 7.8 months); biopsies showed unmasking of hidden lymphoma.
- International Journal of Dermatology (2023): Systematic review of 18 cases. 100% had >50% body involvement pre-diagnosis; advanced stages (III/IV) common. Recommended biopsies 3-4 months post-start if no improvement.
- Blood Journal (November 2023): 25 MSK Cancer Center patients. Median time to CTCL diagnosis: 10 months. No survival difference vs. non-Dupixent CTCL cases, but progression often accelerated.
Other Insights and Key Findings
- 2025: The FDA is reviewing post-marketing reports of CTCL in Dupixent users but has not issued a recall.
- Current labeling: Dupixent’s warning label does not specifically mention lymphoma, creating a potential “failure-to-warn” claim.
FDA FAERS (as of January 2026): Nearly 300 lymphoma reports (138 CTCL-specific), prompting ongoing review for label updates. No direct causation is proven, but this is a strong signal of correlation.
Who Qualifies for a Dupixent Lawsuit in Georgia?
You may qualify if:
✅ You took Dupixent (dupilumab) for eczema, asthma, or another approved condition.
✅ You were later diagnosed with CTCL, Mycosis Fungoides, or Sézary syndrome.
✅ Your medical records show Dupixent use before or around the time of diagnosis.
✅ You live in Georgia or were prescribed Dupixent by a Georgia healthcare provider.
✅ You file before Georgia’s statute of limitations expires (generally two years from the date of diagnosis or discovery).
Damages Available in a Georgia Dupixent Lawsuit
Victims in Georgia Dupixent cases may recover compensation for:
- Medical expenses (past and future)
- Lost wages and diminished earning capacity
- Pain and suffering
- Emotional distress
- Wrongful death damages (if applicable)
Our lawyers at Fob James Law Firm will calculate all possible economic and non-economic damages so that you pursue the maximum recovery available under Georgia law.
How Long Do I Have To File a Dupixent CTCL Lawsuit?
In Georgia, most product liability claims must be filed within two years from the date of injury or diagnosis (O.C.G.A. § 9-3-33).
If your diagnosis occurred more than two years ago, exceptions might apply—contact us right away to preserve your rights.
Recent Dupixent Litigation Updates
| Date | Event | Significance for Georgia Claimants |
|---|---|---|
| June 2018 | Early study linked Dupixent to abnormal immune response. | Provided first safety warning data. |
| April 2024 | Retrospective cohort study found 4.5× increased CTCL risk among Dupixent users. | Strengthens causation arguments in litigation. |
| 2025 | Attorneys begin filing individual lawsuits across the U.S., including Georgia. | Georgia residents now pursuing claims. |
| Mid-2025 | FDA reviewing CTCL case reports; no recall or label change yet. | Manufacturers could face failure-to-warn liability. |
| November 2025 | Potential formation of Dupixent MDL under review if case volume rises. | Georgia cases may be consolidated federally later. |
Next Steps for Georgia Residents
If you believe Dupixent caused your cancer or lymphoma:
- Do not stop Dupixent without consulting your doctor.
- Gather all medical records and pathology reports.
- Document your prescription history and symptoms.
- Contact our Georgia Dupixent lawyers for a free case review.
We’ll evaluate your eligibility, guide you through Georgia’s filing process, and help protect your rights.
Frequently Asked Questions
Has the FDA recalled Dupixent?
Not at this time. The FDA continues to evaluate reports of CTCL and other cancers linked to Dupixent.
Can I join a class action?
No Dupixent class action exists yet. However, you can file an individual lawsuit, and if an MDL is formed, your case can be transferred.
What does it cost to hire a lawyer?
We work on a contingency fee basis—you pay nothing unless we win your case.
Where does Fob James Law Firm handle Dupixent lawsuits?
Across Georgia, including Atlanta, Savannah, Augusta, Macon, Columbus, and surrounding areas.
Contact a Georgia Dupixent Lawsuit Lawyer Near Me
If you or a loved one were diagnosed with T-cell lymphoma after using Dupixent, call Fob James Law Firm at 866-837-1010 or complete our online contact form for a free, confidential consultation.
We proudly represent clients throughout Georgia who have been harmed by dangerous and defective drugs. Let us fight for the justice and compensation you deserve.